Human Molecular Genetics, 2002, Vol. 11, No. 4 419-429
© 2002 Oxford University Press
Heterogeneity of linkage disequilibrium in human genes has implications for association studies of common diseases
INSERM U525, Faculté de Médecine, 91 Boulevard de l’Hôpital, 75634 Paris, France
Linkage disequilibrium (LD) is the central concept of genetic association studies. Although LD has been shown not to be uniformly distributed across the genome, limited information is available about the characteristics of LD within candidate genes at large. We screened coding and regulatory regions of 50 candidate genes for cardiovascular diseases and identified 228 polymorphisms. The overall sequence diversity was 3.81 ± 0.31 x 10–4. Intragenic LD was generally very strong, with 40% of the 464 pairs of polymorphisms exhibiting a complete LD. However, if we consider 
D' = 0.7 as an arbitrary limit for useful LD in association studies, 26% of the pairs fell below this threshold, half of which being in negative LD, a situation where LD is even more difficult to detect. Non-synonymous coding polymorphisms, which are more likely to have a functional role, were more represented among low-frequency alleles and were more often in complete negative LD with other polymorphisms. This implies that in many situations the power to detect the effect of a non-synonymous polymorphism by measuring a nearby marker might be low. Although intragenic LD was partly a function of physical distance, gene-specific patterns of LD were observed, making it difficult to provide general guidelines for selecting the most useful polymorphisms in association studies. For all these reasons, association studies should concentrate on the overall sequence variation of functionally important regions of candidate genes and not only on a few polymorphisms. The variability of important intergenic regions identified by different approaches including comparative genomics will also have to be assessed.
+ To whom correspondence should be addressed. Tel: +33 1 40 77 96 70; Fax: +33 1 40 77 97 28; Email: tiret@idf.inserm.fr Present address:Stefan-Martin Herrmann, Institute of Clinical Pharmacology and Toxicology, Department of Clinical Pharmacology, Freie Universität Berlin, Germany
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  I. Mokrousov, N. Sapozhnikova, and O. Narvskaya Mycobacterium tuberculosis co-existence with humans: making an imprint on the macrophage P2X7 receptor gene? J. Med. Microbiol., May 1, 2008; 57(5): 581 - 584. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M Persico, M Capasso, R Russo, E Persico, L Croce, C Tiribelli, and A Iolascon Elevated expression and polymorphisms of SOCS3 influence patient response to antiviral therapy in chronic hepatitis C Gut, April 1, 2008; 57(4): 507 - 515. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J-R Long, H Xu, L-J Zhao, P-Y Liu, H Shen, Y-J Liu, D-H Xiong, P Xiao, Y-Z Liu, V Dvornyk, et al. The oestrogen receptor {alpha} gene is linked and/or associated with age of menarche in different ethnic groups J. Med. Genet., October 1, 2005; 42(10): 796 - 800. [Full Text] [PDF]
|
|
|
|
 |
|
 L. Tiret, T. Godefroy, E. Lubos, V. Nicaud, D.-A. Tregouet, S. Barbaux, R. Schnabel, C. Bickel, C. Espinola-Klein, O. Poirier, et al. Genetic Analysis of the Interleukin-18 System Highlights the Role of the Interleukin-18 Gene in Cardiovascular Disease Circulation, August 2, 2005; 112(5): 643 - 650. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Ninio, D. Tregouet, J.-L. Carrier, D. Stengel, C. Bickel, C. Perret, H. J. Rupprecht, F. Cambien, S. Blankenberg, and L. Tiret Platelet-activating factor-acetylhydrolase and PAF-receptor gene haplotypes in relation to future cardiovascular event in patients with coronary artery disease Hum. Mol. Genet., July 1, 2004; 13(13): 1341 - 1351. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Blons, S. Gad, F. Zinzindohoue, I. Maniere, J. Beauregard, D. Tregouet, D. Brasnu, P. Beaune, O. Laccourreye, and P. Laurent-Puig Matrix Metalloproteinase 3 Polymorphism: A Predictive Factor of Response to Neoadjuvant Chemotherapy in Head and Neck Squamous Cell Carcinoma Clin. Cancer Res., April 15, 2004; 10(8): 2594 - 2599. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Jaakkola, A. M. Crane, K. Laiho, I. Herzberg, A.-M. Sims, L. Bradbury, A. Calin, S. Brophy, M. Kauppi, K. Kaarela, et al. The effect of transforming growth factor {beta}1 gene polymorphisms in ankylosing spondylitis Rheumatology, January 1, 2004; 43(1): 32 - 38. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Freudenberg-Hua, J. Freudenberg, N. Kluck, S. Cichon, P. Propping, and M. M. Nothen Single Nucleotide Variation Analysis in 65 Candidate Genes for CNS Disorders in a Representative Sample of the European Population Genome Res., October 1, 2003; 13(10): 2271 - 2276. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. C.J. Twells, C. A. Mein, M. S. Phillips, J. F. Hess, R. Veijola, M. Gilbey, M. Bright, M. Metzker, B. A. Lie, A. Kingsnorth, et al. Haplotype Structure, LD Blocks, and Uneven Recombination Within the LRP5 Gene Genome Res., May 1, 2003; 13(5): 845 - 855. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Funke-Kaiser, F. Reichenberger, K. Kopke, S.-M. Herrmann, J. Pfeifer, H.-D. Orzechowski, W. Zidek, M. Paul, and E. Brand Differential binding of transcription factor E2F-2 to the endothelin-converting enzyme-1b promoter affects blood pressure regulation Hum. Mol. Genet., February 15, 2003; 12(4): 423 - 433. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Almasy and J.W. MacCluer Association Studies of Vascular Phenotypes: How and Why? Arterioscler Thromb Vasc Biol, July 1, 2002; 22(7): 1055 - 1057. [Full Text] [PDF]
|
|